FI875157A0 - Imidazopyridinfoereningar och foerfarande foer deras framstaellning. - Google Patents

Imidazopyridinfoereningar och foerfarande foer deras framstaellning.

Info

Publication number
FI875157A0
FI875157A0 FI875157A FI875157A FI875157A0 FI 875157 A0 FI875157 A0 FI 875157A0 FI 875157 A FI875157 A FI 875157A FI 875157 A FI875157 A FI 875157A FI 875157 A0 FI875157 A0 FI 875157A0
Authority
FI
Finland
Prior art keywords
imidazopyridinfoereningar
foerfarande foer
och foerfarande
deras framstaellning
foer deras
Prior art date
Application number
FI875157A
Other languages
English (en)
Other versions
FI875157A (fi
Inventor
Youichi Shiokawa
Masanobu Nagano
Hiromichi Itani
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868628262A external-priority patent/GB8628262D0/en
Priority claimed from GB878723439A external-priority patent/GB8723439D0/en
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of FI875157A0 publication Critical patent/FI875157A0/fi
Publication of FI875157A publication Critical patent/FI875157A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/73—Unsubstituted amino or imino radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI875157A 1986-11-26 1987-11-23 Imidazopyridinfoereningar och foerfarande foer deras framstaellning. FI875157A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB868628262A GB8628262D0 (en) 1986-11-26 1986-11-26 Imidazopyridine compounds
GB878723439A GB8723439D0 (en) 1987-10-06 1987-10-06 Imidazopyridine compounds

Publications (2)

Publication Number Publication Date
FI875157A0 true FI875157A0 (fi) 1987-11-23
FI875157A FI875157A (fi) 1988-05-27

Family

ID=26291587

Family Applications (1)

Application Number Title Priority Date Filing Date
FI875157A FI875157A (fi) 1986-11-26 1987-11-23 Imidazopyridinfoereningar och foerfarande foer deras framstaellning.

Country Status (13)

Country Link
US (1) US4831041A (fi)
EP (1) EP0268989B1 (fi)
KR (1) KR880006237A (fi)
CN (1) CN87108027A (fi)
AU (1) AU8169387A (fi)
DE (1) DE3780263T2 (fi)
DK (1) DK608887A (fi)
ES (1) ES2064310T3 (fi)
FI (1) FI875157A (fi)
GR (1) GR3005685T3 (fi)
HU (1) HUT45526A (fi)
IL (1) IL84522A0 (fi)
NO (1) NO874904L (fi)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4725601A (en) * 1985-06-04 1988-02-16 Fujisawa Pharmaceutical Co., Ltd. Certain imidazo[1,2-a]pyridines useful in the treatment of ulcers
US4791117A (en) * 1986-09-22 1988-12-13 Ortho Pharmaceutical Corporation 2- or 3-aryl substituted imidazo[1,2-a]pyridines and their use as calcium channel blockers
ATE145907T1 (de) * 1987-07-16 1996-12-15 Byk Gulden Lomberg Chem Fab Imidazo(1,2-a>pyridine
GB8722488D0 (en) * 1987-09-24 1987-10-28 Fujisawa Pharmaceutical Co Imidazopyridine compound
CA2048110C (en) * 1990-07-30 2002-06-25 Muneo Takatani Imidazopyridine derivatives and their use
MY110439A (en) * 1991-02-07 1998-05-30 Ishihara Sangyo Kaisha N-phenylcarbamate compound, process for preparing the same and biocidal composition for control of harmful organisms
GB9201693D0 (en) * 1992-01-27 1992-03-11 Smithkline Beecham Intercredit Compounds
US5574042A (en) * 1992-11-02 1996-11-12 Fujisawa Pharmaceutical Co., Ltd Imidazo [1,2-a] pyridines and their pharmaceutical use
IL108520A (en) * 1993-02-15 1997-09-30 Byk Gulden Lomberg Chem Fab 2, 3, 8-TRISUBSTITUTED IMIDAZO £1, 2-a| PYRIDINE DERIVATIVES, PROCESSES FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
UA48122C2 (uk) * 1993-10-11 2002-08-15 Бік Гульден Ломберг Хеміше Фабрік Гмбх АЛКОКСІАЛКІЛКАРБАМАТИ ІМІДАЗО[1,2-а]ПІРИДИНІВ, СПОСІБ ЇХ ОДЕРЖАННЯ ТА ЛІКАРСЬКИЙ ЗАСІБ НА ЇХ ОСНОВІ
EP0772614A1 (de) * 1994-07-28 1997-05-14 Byk Gulden Lomberg Chemische Fabrik GmbH Halogenimidazopyridine
SK197A3 (en) * 1994-07-28 1997-06-04 Byk Gulden Lomberg Chem Fab Imidazopyridine-azolidinones, preparation method thereof, pharmaceutical composition containing same and their use
CA2196077A1 (en) * 1994-07-28 1996-02-08 Georg Rainer Benzyl-imidazopyridines
AU1545297A (en) * 1996-01-26 1997-08-20 Byk Gulden Imidazopyridine halides
ATE294802T1 (de) * 1996-01-26 2005-05-15 Altana Pharma Ag 3-alkylimidazopyridine
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
DE10145457A1 (de) 2001-09-14 2003-04-03 Basf Ag Substituierte Imidazo[1,2-a]-5,6,7,8-tetrahydropyridin-8-one, Verfahren zu ihrer Herstellung, sowie deren Verwendung zur Herstellung von Imidazo[1,2,-a]pyridinen
MY140561A (en) * 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
EP1606261B1 (en) 2003-03-10 2009-11-04 Nycomed GmbH Novel process for the preparation of roflumilast
CA2601250C (en) * 2005-03-16 2014-10-28 Nycomed Gmbh Taste masked dosage form containing roflumilast
FI3738434T3 (fi) * 2011-12-28 2023-11-20 Global Blood Therapeutics Inc Välituotteita substituoitujen bentsaldehydiyhdisteiden saamiseksi ja menetelmiä niiden käyttöön kudosten hapetuksen lisäämiseksi
US9012450B2 (en) 2011-12-28 2015-04-21 Global Blood Therapeutics, Inc. Substituted heteroaryl aldehyde compounds and methods for their use in increasing tissue oxygenation
US10100043B2 (en) 2013-03-15 2018-10-16 Global Blood Therapeutics, Inc. Substituted aldehyde compounds and methods for their use in increasing tissue oxygenation
US20140274961A1 (en) 2013-03-15 2014-09-18 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
SG11201507349TA (en) 2013-03-15 2015-10-29 Global Blood Therapeutics Inc Compounds and uses thereof for the modulation of hemoglobin
AU2014237330A1 (en) 2013-03-15 2015-09-17 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US9458139B2 (en) 2013-03-15 2016-10-04 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US8952171B2 (en) 2013-03-15 2015-02-10 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US9802900B2 (en) 2013-03-15 2017-10-31 Global Blood Therapeutics, Inc. Bicyclic heteroaryl compounds and uses thereof for the modulation of hemoglobin
MX2015011445A (es) 2013-03-15 2016-04-20 Global Blood Therapeutics Inc Compuestos y usos de estos para la modulacion de la hemoglobina.
US9422279B2 (en) 2013-03-15 2016-08-23 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US10266551B2 (en) 2013-03-15 2019-04-23 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
EA202092627A1 (ru) 2013-11-18 2021-09-30 Глобал Блад Терапьютикс, Инк. Соединения и их применения для модуляции гемоглобина
AP2016009261A0 (en) 2014-02-07 2016-06-30 Global Blood Therapeutics Inc Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde
MA41841A (fr) 2015-03-30 2018-02-06 Global Blood Therapeutics Inc Composés aldéhyde pour le traitement de la fibrose pulmonaire, de l'hypoxie, et de maladies auto-immunes et des tissus conjonctifs
TW201731509A (zh) 2015-12-04 2017-09-16 全球血液治療公司 針對２-羥基-６-（（２-（１-異丙基-１ｈ-吡唑-５-基）吡啶-３-基）甲氧基）-苯甲醛之劑量方案
TWI752307B (zh) 2016-05-12 2022-01-11 美商全球血液治療公司 新穎化合物及製造化合物之方法
TW202332423A (zh) 2016-10-12 2023-08-16 美商全球血液治療公司 包含2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)吡啶-3-基)甲氧基)-苯甲醛之片劑
EP3860975B1 (en) 2018-10-01 2023-10-18 Global Blood Therapeutics, Inc. Modulators of hemoglobin for the treatment of sickle cell disease

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA81219B (en) * 1980-01-23 1982-01-27 Schering Corp Imidazo (1,2-a) pyridines ,process for their preparation and pharmaceutical compositions containing them
EP0068378B1 (en) * 1981-06-26 1986-03-05 Schering Corporation Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them
US4725601A (en) * 1985-06-04 1988-02-16 Fujisawa Pharmaceutical Co., Ltd. Certain imidazo[1,2-a]pyridines useful in the treatment of ulcers
EP0228006A1 (en) * 1985-12-16 1987-07-08 Fujisawa Pharmaceutical Co., Ltd. Imidazopyridine compounds and processes for preparation thereof

Also Published As

Publication number Publication date
KR880006237A (ko) 1988-07-22
EP0268989B1 (en) 1992-07-08
NO874904D0 (no) 1987-11-25
DE3780263T2 (de) 1992-12-24
AU8169387A (en) 1988-06-02
CN87108027A (zh) 1988-06-08
US4831041A (en) 1989-05-16
DK608887A (da) 1988-05-27
ES2064310T3 (es) 1995-02-01
DK608887D0 (da) 1987-11-19
FI875157A (fi) 1988-05-27
DE3780263D1 (de) 1992-08-13
HUT45526A (en) 1988-07-28
IL84522A0 (en) 1988-04-29
GR3005685T3 (fi) 1993-06-07
EP0268989A1 (en) 1988-06-01
NO874904L (no) 1988-05-27

Similar Documents

Publication Publication Date Title
FI870255A (fi) Olja och vatten avstoetande kopolymerer.
FI870275A0 (fi) Fotopolymeriserbar balndning och denna innehaollande fotopolymeriserbara maerkningsaemnen.
FI870233A0 (fi) Vakumisolerad skeppcontainer och foerfarande.
FI875157A0 (fi) Imidazopyridinfoereningar och foerfarande foer deras framstaellning.
FI865351A0 (fi) Luftfoerdelningssystem och luftfoerdelningsanlaeggning.
FI870246A (fi) Antiischemiska och antihypertensiva dihydropyridinfoereningar.
FI862675A0 (fi) Anordning foer provbelastning och kvalitetskontroll.
FI862161A0 (fi) Dragkrok och skyddsanordning foer dragkroket.
FI861422A0 (fi) Skivcylinderlaos och nyckel.
FI864911A0 (fi) Mikrobiologisk odlingskammare och laesapparat.
FI861914A0 (fi) Svetsningsfoerfarande och laongartat svetsningselement.
FI862066A0 (fi) Icke-laosbart bromssystem och tryckavlaegsnare.
FI861988A (fi) Skivcylinderlaos och nyckel.
FI862212A0 (fi) Anordning foer provbelastning och kvalitetkontroll.
FI861114A0 (fi) Svetsningsfoerfarande och laongartad svetsningselektrod.
FI862287A (fi) Fotopolymeriserbar blandning och fotoinitieringssystem.
FI860985A0 (fi) Kombinerad arbetsfoerstaendingandeblankett och foerpackningskuvert foer glasoegonlinser.
FI860970A0 (fi) Foerfarande foer traodbaogsvetsning och skaerbraenning.
FI860706A0 (fi) Sammanfogningsmetod foer fyrkantskanaler och luftkonditioneringsmaskiner.
FI864132A0 (fi) Haolighetskonstruktion och foerfarande foer framstaellning daerav.
FI860691A (fi) Byggnadssystem och vaeggelement.
FI864174A0 (fi) Framstaellningsfoerfarande foer kombinerat fosforgoedslingsmedel och jordfoerbaettringsmedel.
FI860535A0 (fi) Roerbyggd staellning foer haengmatta reservbaedd och torkning.
FI860436A0 (fi) Tilltaeppningsborttagare och rensare foer vattenavloppsroer.
FI864115A0 (fi) Foerfarande och anlaeggning foer vaermekraftsprocess.

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: FUJISAWA PHARMACEUTICAL CO., LTD.